Top

Published in:

01-03-2008 | SSAT other

Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Author: Michael B. Farnell

Published in: Journal of Gastrointestinal Surgery | Issue 3/2008

Abstract

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is characterized by papillary growths within the pancreatic ductal system that are at risk for undergoing malignant transformation. Main duct IPMN carries a significant risk of malignancy, and operation is recommended regardless of the presence of symptoms. The risk of malignancy is much lower for side branch IPMN, and current evidence suggests that, in the absence of symptoms, mural nodules, positive cytology, or cyst size less than 3 cm, observation is warranted. When operation is indicated, targeted pancreatic resection with frozen-section analysis of margins is recommended. Pancreatoduodenectomy or distal pacreatectomy is appropriate for the majority. Only in about 10% of patients is the disease so diffuse at presentation that total pancreatectomy is necessary. Survival following pancreatic resection for noninvasive IPMN is excellent. The risk of recurrence following pancreatic resection for invasive IPMN is significant. Surveillance is warranted both for patients subjected to pancreatic resection and for those under observation with side branch IPMN. Much is yet to be learned regarding this neoplasm, and surgical management remains in evolution.

Longnecker DS, Adler G, Hruban RH, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In Hamilton SR, Aaltonen LA, eds: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000, pp 237–241.

Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–31.PubMedCrossRef

Brugge WR, Lewandrowski K, Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330–1336.PubMedCrossRef

Pinto MM, Meriano FV. Diagnosis of cystic pancreatic lesions by cytologic examination and carcinoembryonic antigen and amylase assays of cyst contents. Acta Cytol 1991;35:456–463.PubMed

Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types. Am J Surg 2006;30:1561–1569.CrossRef

Serikawa M, Sasaki T, Fujimoto Y, et al. Management of intraductal papillary-mucinous neoplasm of the pancreas. Treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856–862.PubMedCrossRef

Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999;134:1131–1136.PubMedCrossRef

Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372–1377.PubMedCrossRef

Doi R, Fujimoto K, Wada M, et al. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 2002;132:80–85.PubMedCrossRef

10.

Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003;36:261–265.PubMedCrossRef

11.

Choi BS, Kim TK, Kim AY, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol 2003;4:157–162.PubMedCrossRef

12.

Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003;7:12–19.PubMedCrossRef

13.

Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg 2003;90:1244–1249.PubMedCrossRef

14.

Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788–799.PubMedCrossRef

15.

Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678–687.PubMedCrossRef

16.

Pelaez-Luna M, Chari ST, Smyrk T, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007;102:1759–1764.PubMedCrossRef

17.

Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas. J Gastrointest Surg 2003;7:417–428.PubMedCrossRef

18.

Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med 2004;351:1218–1226.PubMedCrossRef

19.

Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500–1507.PubMedCrossRef

20.

Traverso LW, Peralta EA, Ryan JA, et al. Intraductal neoplasms of the pancreas. Am J Surg 1998;175:426–432.PubMedCrossRef

21.

Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95:441–445.PubMedCrossRef

22.

Paye R, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas. Pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000;127:536–544.PubMedCrossRef

23.

Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001;234:313–322.PubMedCrossRef

24.

Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up? J Gastrointest Surg 2005;9:1059–1067.PubMedCrossRef

Title: Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Author: Michael B. Farnell
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 3/2008
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-007-0349-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

Primary Sclerosing Cholangitis: Role of Liver Transplantation

Cystic Neoplasia of the Pancreas: Pathology and Biology

Postoperative Complications have Little Influence on Long-term Quality of Life in Crohn’s Patients

Postoperative Adjuvant Chemotherapy Improves Survival after Surgical Resection for Pancreatic Carcinoma

Surgical Treatment of Gastroesophageal Reflux Disease and Upside-down Stomach Using the Da Vinci® Robotic System. A Prospective Study

Surgical Approaches to Strictures in Primary Sclerosing Cholangitis